We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PDC Biotech GmbH Announces Successful Clinical Phase I for its Lead Compound PDC31

Product News   Dec 14, 2012

 
PDC Biotech GmbH Announces Successful Clinical Phase I for its Lead Compound PDC31
 
 
FURTHER INFORMATION
 
 
 

Related Product News

QIAGEN’s CareHPV™ Test Wins WHO Prequalification Status for Cervical Cancer Screening

Product News

Advancing science and healthcare in a region with increasing demands for modern molecular testing solutions.

READ MORE

Exploring Personalized Treatments for Bladder Cancer with scRNA-seq

Product News

Dolomite Bio system is helping researchers in the Department of Molecular Medicine at Aarhus University Hospital in Denmark.

READ MORE

Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project

Product News

Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE